Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caloric Restriction | 2 | 2019 | 92 | 0.810 |
Why?
|
| Exercise | 4 | 2019 | 587 | 0.720 |
Why?
|
| Obesity | 4 | 2019 | 1062 | 0.670 |
Why?
|
| Geriatric Assessment | 10 | 2016 | 355 | 0.510 |
Why?
|
| Gene Expression | 2 | 2006 | 332 | 0.500 |
Why?
|
| Disability Evaluation | 4 | 2019 | 210 | 0.490 |
Why?
|
| Aged | 28 | 2019 | 9462 | 0.480 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 1007 | 0.450 |
Why?
|
| Aging | 8 | 2016 | 880 | 0.440 |
Why?
|
| Female | 36 | 2019 | 18114 | 0.410 |
Why?
|
| Lung | 1 | 2013 | 233 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 155 | 0.370 |
Why?
|
| Women's Health | 3 | 2016 | 226 | 0.360 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 320 | 0.350 |
Why?
|
| Motor Activity | 4 | 2016 | 310 | 0.340 |
Why?
|
| Male | 32 | 2019 | 17768 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 871 | 0.330 |
Why?
|
| Morphogenesis | 1 | 2008 | 10 | 0.320 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 68 | 0.310 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 38 | 0.310 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 43 | 0.310 |
Why?
|
| Humans | 36 | 2019 | 29013 | 0.300 |
Why?
|
| Oral Health | 4 | 2011 | 29 | 0.300 |
Why?
|
| Aged, 80 and over | 16 | 2017 | 3712 | 0.300 |
Why?
|
| Rural Population | 4 | 2012 | 244 | 0.280 |
Why?
|
| Biometry | 1 | 2006 | 12 | 0.280 |
Why?
|
| Exercise Test | 3 | 2019 | 194 | 0.280 |
Why?
|
| Computational Biology | 1 | 2005 | 86 | 0.270 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 110 | 0.240 |
Why?
|
| Exercise Therapy | 3 | 2019 | 229 | 0.240 |
Why?
|
| Signal Transduction | 1 | 2008 | 666 | 0.240 |
Why?
|
| Tongue | 2 | 2012 | 13 | 0.210 |
Why?
|
| Deglutition | 2 | 2011 | 28 | 0.200 |
Why?
|
| Laryngoscopy | 2 | 2011 | 39 | 0.200 |
Why?
|
| Time Factors | 8 | 2011 | 1997 | 0.190 |
Why?
|
| Respiratory Aspiration | 2 | 2011 | 21 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2016 | 2010 | 0.190 |
Why?
|
| Middle Aged | 19 | 2019 | 10805 | 0.190 |
Why?
|
| Physical Fitness | 2 | 2012 | 119 | 0.180 |
Why?
|
| Body Mass Index | 3 | 2019 | 862 | 0.180 |
Why?
|
| Age Factors | 6 | 2012 | 1105 | 0.170 |
Why?
|
| Fatigue | 1 | 2019 | 68 | 0.170 |
Why?
|
| Risk Factors | 6 | 2018 | 3509 | 0.170 |
Why?
|
| Quality of Life | 6 | 2016 | 815 | 0.170 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 138 | 0.170 |
Why?
|
| Hand Strength | 4 | 2012 | 85 | 0.170 |
Why?
|
| Diet | 2 | 2011 | 348 | 0.160 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 724 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 784 | 0.160 |
Why?
|
| United States | 5 | 2018 | 3604 | 0.160 |
Why?
|
| Cause of Death | 1 | 2018 | 219 | 0.150 |
Why?
|
| Inflammation | 2 | 2012 | 503 | 0.150 |
Why?
|
| Incidence | 2 | 2018 | 1105 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2019 | 465 | 0.140 |
Why?
|
| Deglutition Disorders | 3 | 2011 | 50 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 481 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2008 | 272 | 0.140 |
Why?
|
| Genes, Fungal | 2 | 2006 | 4 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 706 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2008 | 202 | 0.140 |
Why?
|
| Diet Surveys | 3 | 2011 | 56 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2006 | 69 | 0.140 |
Why?
|
| Independent Living | 1 | 2016 | 77 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2018 | 1300 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2015 | 24 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 141 | 0.130 |
Why?
|
| Cross-Sectional Studies | 7 | 2012 | 1353 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2006 | 160 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 237 | 0.130 |
Why?
|
| Mobility Limitation | 1 | 2016 | 187 | 0.130 |
Why?
|
| Animals | 6 | 2012 | 7297 | 0.120 |
Why?
|
| Survivors | 1 | 2016 | 145 | 0.120 |
Why?
|
| Resistance Training | 1 | 2015 | 70 | 0.120 |
Why?
|
| Weight Loss | 2 | 2014 | 413 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2012 | 19 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2014 | 89 | 0.120 |
Why?
|
| Movement | 1 | 2014 | 40 | 0.120 |
Why?
|
| Algorithms | 2 | 2008 | 461 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2016 | 670 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 208 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2010 | 128 | 0.110 |
Why?
|
| Motor Cortex | 2 | 2014 | 12 | 0.110 |
Why?
|
| Food | 2 | 2011 | 41 | 0.110 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 8 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 256 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 10 | 0.110 |
Why?
|
| Life Style | 1 | 2014 | 363 | 0.110 |
Why?
|
| Dental Health Services | 1 | 2012 | 8 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 5 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 101 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 97 | 0.110 |
Why?
|
| Gastrointestinal Transit | 1 | 2011 | 4 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 2011 | 8 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2016 | 1674 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2012 | 131 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 38 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2011 | 61 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2011 | 14 | 0.100 |
Why?
|
| Infant Welfare | 1 | 2011 | 3 | 0.100 |
Why?
|
| Phonation | 1 | 2011 | 1 | 0.100 |
Why?
|
| Maternal Welfare | 1 | 2011 | 6 | 0.100 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 9 | 0.100 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 15 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2012 | 74 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2012 | 139 | 0.100 |
Why?
|
| Cytokines | 1 | 2012 | 243 | 0.100 |
Why?
|
| Xerostomia | 1 | 2011 | 29 | 0.100 |
Why?
|
| Cognition | 2 | 2019 | 524 | 0.100 |
Why?
|
| Stroke | 2 | 2014 | 522 | 0.100 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 8 | 0.100 |
Why?
|
| Adiposity | 1 | 2012 | 191 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 120 | 0.100 |
Why?
|
| Biostatistics | 1 | 2010 | 8 | 0.100 |
Why?
|
| Stomatognathic Diseases | 1 | 2010 | 5 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 22 | 0.090 |
Why?
|
| Sex Factors | 4 | 2017 | 626 | 0.090 |
Why?
|
| Social Support | 1 | 2011 | 163 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2010 | 40 | 0.090 |
Why?
|
| Food Preferences | 1 | 2010 | 35 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2010 | 61 | 0.090 |
Why?
|
| Bicycling | 1 | 2009 | 12 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2009 | 32 | 0.090 |
Why?
|
| Mouth, Edentulous | 1 | 2009 | 4 | 0.090 |
Why?
|
| Acetabulum | 1 | 2010 | 29 | 0.090 |
Why?
|
| Nutrition Disorders | 1 | 2009 | 12 | 0.090 |
Why?
|
| Dental Care for Aged | 1 | 2009 | 5 | 0.090 |
Why?
|
| Neoplasms | 1 | 2016 | 608 | 0.090 |
Why?
|
| Oral Hygiene | 1 | 2009 | 15 | 0.090 |
Why?
|
| Health Surveys | 3 | 2016 | 191 | 0.090 |
Why?
|
| Probability | 2 | 2009 | 150 | 0.090 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2010 | 43 | 0.090 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 15 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2009 | 68 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2010 | 159 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 146 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2009 | 93 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 134 | 0.080 |
Why?
|
| Geriatrics | 1 | 2010 | 94 | 0.080 |
Why?
|
| Capillaries | 1 | 2008 | 23 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2010 | 153 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2106 | 0.080 |
Why?
|
| Quadriceps Muscle | 1 | 2008 | 31 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2009 | 133 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 436 | 0.080 |
Why?
|
| Health Status | 3 | 2016 | 368 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2010 | 149 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 160 | 0.080 |
Why?
|
| Health Behavior | 1 | 2009 | 212 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 103 | 0.080 |
Why?
|
| Comorbidity | 1 | 2009 | 539 | 0.070 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 389 | 0.070 |
Why?
|
| Dementia | 1 | 2009 | 233 | 0.070 |
Why?
|
| North Carolina | 4 | 2012 | 1422 | 0.070 |
Why?
|
| Genes, Insect | 1 | 2006 | 4 | 0.070 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 29 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 14 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1374 | 0.070 |
Why?
|
| Dictyostelium | 1 | 2005 | 1 | 0.070 |
Why?
|
| Fungal Proteins | 1 | 2005 | 5 | 0.070 |
Why?
|
| Ethanol | 1 | 2008 | 185 | 0.070 |
Why?
|
| Stochastic Processes | 1 | 2005 | 4 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2005 | 12 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2006 | 92 | 0.070 |
Why?
|
| Drosophila | 1 | 2006 | 34 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 60 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 243 | 0.070 |
Why?
|
| Models, Biological | 1 | 2008 | 372 | 0.070 |
Why?
|
| Linear Models | 3 | 2012 | 425 | 0.070 |
Why?
|
| Software | 1 | 2005 | 109 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 636 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 348 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 518 | 0.060 |
Why?
|
| Heart Failure | 1 | 2009 | 567 | 0.060 |
Why?
|
| Hypertension | 1 | 2009 | 899 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 229 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2016 | 446 | 0.050 |
Why?
|
| Laryngoscopes | 2 | 2011 | 12 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3099 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 224 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2014 | 182 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 292 | 0.050 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1131 | 0.050 |
Why?
|
| Body Composition | 2 | 2014 | 365 | 0.050 |
Why?
|
| Logistic Models | 2 | 2012 | 725 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 531 | 0.040 |
Why?
|
| Executive Function | 1 | 2019 | 54 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 711 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2011 | 595 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 385 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 378 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 24 | 0.040 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 350 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2017 | 221 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 2368 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 104 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2015 | 67 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 315 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 291 | 0.030 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Motor Skills | 1 | 2014 | 12 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2014 | 59 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 121 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 58 | 0.030 |
Why?
|
| Young Adult | 2 | 2011 | 2398 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2014 | 90 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2014 | 52 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 97 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2014 | 139 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3107 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 3248 | 0.030 |
Why?
|
| Chemokine CCL21 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Stifle | 1 | 2012 | 4 | 0.030 |
Why?
|
| Interleukins | 1 | 2012 | 17 | 0.030 |
Why?
|
| Esophageal Motility Disorders | 1 | 2011 | 6 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 45 | 0.030 |
Why?
|
| Viscosity | 1 | 2011 | 21 | 0.030 |
Why?
|
| Hindlimb | 1 | 2012 | 57 | 0.030 |
Why?
|
| Tibia | 1 | 2012 | 56 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 6 | 0.030 |
Why?
|
| Gait | 1 | 2012 | 115 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2012 | 68 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 148 | 0.030 |
Why?
|
| Indians, North American | 1 | 2011 | 108 | 0.030 |
Why?
|
| Beverages | 1 | 2011 | 19 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2011 | 39 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 4 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 11 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2011 | 107 | 0.020 |
Why?
|
| Psychometrics | 1 | 2011 | 129 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 162 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 98 | 0.020 |
Why?
|
| Rural Health | 1 | 2010 | 43 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 71 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 95 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 167 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2010 | 62 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 226 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 60 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 249 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2010 | 11 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 454 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 82 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2009 | 46 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 44 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 296 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 42 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 72 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2009 | 30 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 74 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 114 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 10 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 182 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 285 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 298 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 194 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 892 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 799 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 807 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 224 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 177 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 177 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 967 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 200 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 8391 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 427 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 190 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 855 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 369 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 278 | 0.020 |
Why?
|
| Self Administration | 1 | 2008 | 296 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 863 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 494 | 0.020 |
Why?
|
| African Americans | 1 | 2011 | 1373 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 1218 | 0.010 |
Why?
|
| Child | 1 | 2010 | 2209 | 0.010 |
Why?
|